A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement

The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Surgeons 2005-08, Vol.201 (2), p.188-193
Hauptverfasser: Sato, Yusuke, Motoyama, Satoru, Maruyama, Kiyotomi, Okuyama, Manabu, Ogawa, Junichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 193
container_issue 2
container_start_page 188
container_title Journal of the American College of Surgeons
container_volume 201
creator Sato, Yusuke
Motoyama, Satoru
Maruyama, Kiyotomi
Okuyama, Manabu
Ogawa, Junichi
description The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death. Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times. The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.
doi_str_mv 10.1016/j.jamcollsurg.2005.03.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68070759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1072751505003261</els_id><sourcerecordid>68070759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSMEoqXwCsgsYJdgx_HfsgoFRhoKUsva8jg3f3LiqZ2MNM_AS-PRjFSWLCxfXX33-vicLPtAcEEw4Z_HYjST9c7FNXRFiTErMC0woS-yayKFyglR-GWqsShzwQi7yt7EOGJMBFb8dXZFOKZSkuo6-3OLHsD6uUE_jBu62cz2iDYRLT2kzugDqs0aAfkWfQGz9MhMfu7QY--DsYNFD09r6qwR1eAcuot-35sOjEtjs4WAfpllgHmJ6B66VB4AtWnn9jjte3TvG0Cb-eDdAaYEvc1etcZFeHe5b7LfX-8e6-_59ue3TX27zW0lyJJzQVXDGiV3lAFhO0kMk5JzQ9MBplossABRYqWULCsuqUxAxSQnTOyUoTfZp_PeffBPK8RFT0O0Sb-ZIX1Fc3nawFQC1Rm0wccYoNX7MEwmHDXB-pSEHvU_SehTEhpTnZJIs-8vj6y7CZrnyYv1Cfh4AUy0xrUhGTbEZ05gUpbVSUR95iBZchgg6GiTpRaaIYBddOOH_5DzF4mPrJI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68070759</pqid></control><display><type>article</type><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</creator><creatorcontrib>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</creatorcontrib><description>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death. Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times. The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</description><identifier>ISSN: 1072-7515</identifier><identifier>EISSN: 1879-1190</identifier><identifier>DOI: 10.1016/j.jamcollsurg.2005.03.013</identifier><identifier>PMID: 16038814</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aftercare ; Aged ; Aged, 80 and over ; Analysis of Variance ; Biological and medical sciences ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - therapy ; Cause of Death ; Esophageal Neoplasms - mortality ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - therapy ; Esophagectomy ; Female ; Follow-Up Studies ; General aspects ; Health Services Needs and Demand ; Hospitals, University ; Humans ; Japan - epidemiology ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Medical sciences ; Middle Aged ; Morbidity ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - therapy ; Neoplasm Staging ; Neoplasms, Second Primary - mortality ; Neoplasms, Second Primary - pathology ; Neoplasms, Second Primary - therapy ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Survival Analysis</subject><ispartof>Journal of the American College of Surgeons, 2005-08, Vol.201 (2), p.188-193</ispartof><rights>2005 American College of Surgeons</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1072751505003261$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306,69986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17012249$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16038814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Yusuke</creatorcontrib><creatorcontrib>Motoyama, Satoru</creatorcontrib><creatorcontrib>Maruyama, Kiyotomi</creatorcontrib><creatorcontrib>Okuyama, Manabu</creatorcontrib><creatorcontrib>Ogawa, Junichi</creatorcontrib><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><title>Journal of the American College of Surgeons</title><addtitle>J Am Coll Surg</addtitle><description>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death. Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times. The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</description><subject>Aftercare</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Cause of Death</subject><subject>Esophageal Neoplasms - mortality</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - therapy</subject><subject>Esophagectomy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>General aspects</subject><subject>Health Services Needs and Demand</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Lymph Node Excision</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Second Primary - mortality</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Neoplasms, Second Primary - therapy</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><issn>1072-7515</issn><issn>1879-1190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhSMEoqXwCsgsYJdgx_HfsgoFRhoKUsva8jg3f3LiqZ2MNM_AS-PRjFSWLCxfXX33-vicLPtAcEEw4Z_HYjST9c7FNXRFiTErMC0woS-yayKFyglR-GWqsShzwQi7yt7EOGJMBFb8dXZFOKZSkuo6-3OLHsD6uUE_jBu62cz2iDYRLT2kzugDqs0aAfkWfQGz9MhMfu7QY--DsYNFD09r6qwR1eAcuot-35sOjEtjs4WAfpllgHmJ6B66VB4AtWnn9jjte3TvG0Cb-eDdAaYEvc1etcZFeHe5b7LfX-8e6-_59ue3TX27zW0lyJJzQVXDGiV3lAFhO0kMk5JzQ9MBplossABRYqWULCsuqUxAxSQnTOyUoTfZp_PeffBPK8RFT0O0Sb-ZIX1Fc3nawFQC1Rm0wccYoNX7MEwmHDXB-pSEHvU_SehTEhpTnZJIs-8vj6y7CZrnyYv1Cfh4AUy0xrUhGTbEZ05gUpbVSUR95iBZchgg6GiTpRaaIYBddOOH_5DzF4mPrJI</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Sato, Yusuke</creator><creator>Motoyama, Satoru</creator><creator>Maruyama, Kiyotomi</creator><creator>Okuyama, Manabu</creator><creator>Ogawa, Junichi</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><author>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aftercare</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Cause of Death</topic><topic>Esophageal Neoplasms - mortality</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - therapy</topic><topic>Esophagectomy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>General aspects</topic><topic>Health Services Needs and Demand</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Lymph Node Excision</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Second Primary - mortality</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Neoplasms, Second Primary - therapy</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Yusuke</creatorcontrib><creatorcontrib>Motoyama, Satoru</creatorcontrib><creatorcontrib>Maruyama, Kiyotomi</creatorcontrib><creatorcontrib>Okuyama, Manabu</creatorcontrib><creatorcontrib>Ogawa, Junichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Surgeons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Yusuke</au><au>Motoyama, Satoru</au><au>Maruyama, Kiyotomi</au><au>Okuyama, Manabu</au><au>Ogawa, Junichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</atitle><jtitle>Journal of the American College of Surgeons</jtitle><addtitle>J Am Coll Surg</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>201</volume><issue>2</issue><spage>188</spage><epage>193</epage><pages>188-193</pages><issn>1072-7515</issn><eissn>1879-1190</eissn><abstract>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death. Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times. The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16038814</pmid><doi>10.1016/j.jamcollsurg.2005.03.013</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1072-7515
ispartof Journal of the American College of Surgeons, 2005-08, Vol.201 (2), p.188-193
issn 1072-7515
1879-1190
language eng
recordid cdi_proquest_miscellaneous_68070759
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aftercare
Aged
Aged, 80 and over
Analysis of Variance
Biological and medical sciences
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Cause of Death
Esophageal Neoplasms - mortality
Esophageal Neoplasms - pathology
Esophageal Neoplasms - therapy
Esophagectomy
Female
Follow-Up Studies
General aspects
Health Services Needs and Demand
Hospitals, University
Humans
Japan - epidemiology
Lymph Node Excision
Lymphatic Metastasis
Male
Medical sciences
Middle Aged
Morbidity
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - therapy
Neoplasm Staging
Neoplasms, Second Primary - mortality
Neoplasms, Second Primary - pathology
Neoplasms, Second Primary - therapy
Prognosis
Proportional Hazards Models
Risk Factors
Survival Analysis
title A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T09%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Second%20Malignancy%20Is%20the%20Major%20Cause%20of%20Death%20among%20Thoracic%20Squamous%20Cell%20Esophageal%20Cancer%20Patients%20Negative%20for%20Lymph%20Node%20Involvement&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Surgeons&rft.au=Sato,%20Yusuke&rft.date=2005-08-01&rft.volume=201&rft.issue=2&rft.spage=188&rft.epage=193&rft.pages=188-193&rft.issn=1072-7515&rft.eissn=1879-1190&rft_id=info:doi/10.1016/j.jamcollsurg.2005.03.013&rft_dat=%3Cproquest_cross%3E68070759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68070759&rft_id=info:pmid/16038814&rft_els_id=S1072751505003261&rfr_iscdi=true